Sign In
Buy GOSS
$0.188
-0.0119 (-5.94%)
At Close: Jun 03, 2026
Insider Buying: Gossamer Bio Inc (NASDAQ:GOSS) CFO Purchases $25,920.00 in Stock
05:48am, Friday, 26'th Jun 2020
Gossamer Bio Inc (NASDAQ:GOSS) CFO Bryan Giraudo acquired 2,000 shares of the company’s stock in a transaction dated Tuesday, June 23rd. The stock was purchased at an average cost of $12.96 per shar
Gossamer Bio (NASDAQ:GOSS) Upgraded to Hold at Zacks Investment Research
01:34am, Wednesday, 24'th Jun 2020
Gossamer Bio (NASDAQ:GOSS) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note issued to investors on Wednesday, Zacks.com reports. According t
Zacks Investment Research Downgrades Gossamer Bio (NASDAQ:GOSS) to Sell
01:48am, Friday, 19'th Jun 2020
Gossamer Bio (NASDAQ:GOSS) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Wednesday, Zacks.com repo
Gossamer Bio Inc (NASDAQ:GOSS) Shares Acquired by Alliancebernstein L.P.
07:26am, Thursday, 18'th Jun 2020
Alliancebernstein L.P. lifted its stake in shares of Gossamer Bio Inc (NASDAQ:GOSS) by 5.5% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commissio
Russell Investments Group Ltd. Lowers Holdings in Gossamer Bio Inc (NASDAQ:GOSS)
05:42am, Tuesday, 16'th Jun 2020
Russell Investments Group Ltd. trimmed its holdings in Gossamer Bio Inc (NASDAQ:GOSS) by 84.6% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commi
Aerpio Hosting Key Opinion Leader Call on a Novel Mechanism for the Treatment of Glaucoma
01:00pm, Monday, 08'th Jun 2020
Aerpio Pharmaceuticals, Inc. (“Aerpio”) (ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular diseases and diabetic complications, today announced
New York, New York--(Newsfile Corp. - June 2, 2020) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Gossamer Bio, Inc. (NASDAQ: GOSS) alleging
New York, New York--(Newsfile Corp. - June 2, 2020) - Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Gossamer Bio, Inc. ("Gossamer " or "the Co
New York, New York--(Newsfile Corp. - June 2, 2020) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Gossamer Bio, Inc. (NASDAQ: GOSS) ("Gossamer" or the "Company")
New York, New York--(Newsfile Corp. - June 2, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of G
NEW YORK, NY / ACCESSWIRE / June 2, 2020 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Gossamer Bio, Inc. ("Gossamer " or "the ...
LAWSUITS FILED AGAINST GOSS, LBRT and FITB - JAKUBOWITZ LAW PURSUES SHAREHOLDERS CLAIMS
04:30pm, Tuesday, 02'nd Jun 2020
NEW YORK, NY / ACCESSWIRE / June 2, 2020 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who
Investors who purchased the Company's securities pursuant and/or traceable to the Company's initial public offering in February 2019 (the "IPO" ) or between February 8, 2019 and December 13, 2019, inc
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of GOSS, SERV and BBBY
03:00pm, Tuesday, 02'nd Jun 2020
NEW YORK, NY / ACCESSWIRE / June 2, 2020 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participa
Los Angeles, California--(Newsfile Corp. - June 2, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Gossamer Bio, Inc.
